Seven additional Phase 3 trials from the TRIUMPH program are expected to report results throughout 2026, including trials in type 2 diabetes, obstructive sleep apnea, and general obesity without specific comorbidities
Eli Lilly continues to advance the clinical development program with results expected in the coming years
If your plan doesnt cover these drugs or you lack insurance, pharmacists can help you find alternative payment options, such as a drug-maker coupon or medication-support program
Oral glutamine increases circulating GLP-1, glucagon and insulin levels in lean, obese and type 2 diabetic subjects
My suggestion for a patient who discussed this with their doctor and decides to use the drug is to make sure that they are using it as instructed and to be patient with any known side effects, including blurry vision. Researchers are working to learn more about the long-term effects of semaglutide on diabetic retinopathy in people with type 2 diabetes
Frequently Asked Questions Is retatrutide FDA approved in 2026